GlassScriptPhysician profile
Fawad Aleem Chaudry
NPI 1467656686
$80,124.05
in general payments reported to CMS, 2019-2025
32 companies · $40K in 2025
The $40K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,768 · 2020: $1,799 · 2021: $2,465 · 2022: $11K · 2023: $608 · 2024: $20K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $40K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,500 · Travel and Lodging: $6,457 · Food and Beverage: $4,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $40,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,500.00 |
| Travel and Lodging | $6,457.31 |
| Food and Beverage | $4,538.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $71,059.45 | 2021-2025 | Da Vinci Surgical System |
| Pinnacle Biologics, INC | $3,992.12 | 2019-2022 | |
| Pulmonx Corporation | $2,040.93 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Veran Medical Technologies, INC. | $1,305.30 | 2019 | |
| Boston Scientific Corporation | $337.45 | 2023 | |
| Olympus America INC. | $164.26 | 2025 | Eves Eus Ultrasound Bronchofibervideoscope, Single-Use Flexible Video Bronchoscope |
| Galvanize Therapeutics, INC | $159.90 | 2023-2025 | Aliya System |
| Ethicon INC. | $137.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $110.48 | 2019 | |
| Steris Corporation | $94.15 | 2021 | |
| Sunovion Pharmaceuticals INC. | $74.40 | 2019 | |
| Gilead Sciences, INC. | $67.66 | 2019-2024 | |
| Pharmacosmos Therapeutics INC. | $59.08 | 2024 | Monoferric |
| La Jolla Pharmaceutical Company | $38.36 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $35.22 | 2024 | Fujifilm |
| Eisai INC. | $31.25 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $27.82 | 2019-2025 | Imfinzi |
| United Therapeutics Corporation | $27.82 | 2019 | |
| Portola Pharmaceuticals, LLC | $25.02 | 2019 | |
| Lilly USA, LLC | $23.91 | 2023 | Retevmo |
| Daiichi Sankyo INC. | $22.98 | 2025 | Datroway |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.07 | 2022 | |
| Incyte Corporation | $19.71 | 2025 | Monjuvi |
| Glaxosmithkline, LLC. | $19.01 | 2019 | |
| Seagen INC. | $18.54 | 2023 | Tukysa |
| Edwards Lifesciences Corporation | $18.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.35 | 2019 | |
| Insmed, INC. | $15.14 | 2019 | |
| Merck Sharp & Dohme LLC | $13.92 | 2020 | |
| Mallinckrodt Enterprises LLC | $13.24 | 2019 | |
| Apria Healthcare LLC | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fawad Chaudry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.